Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SIXD
3276
AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF
SIXD
$386M
| $1.58M | ﹤0.01% |
57,483
-35,062
| -38% | -$927K |
2024 Q4
2 quarters
|
|
3277
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$243M
| $1.58M | ﹤0.01% |
28,446
-2,484
| -8% | -$135K |
2024 Q4
2 quarters
|
|
3278
Qfin Holdings
QFIN
$787M
| $1.57M | ﹤0.01% |
36,199
+21,402
| +145% | +$892K |
2024 Q4
2 quarters
|
|
3279
Zymeworks
ZYME
$1.83B
| $1.56M | ﹤0.01% |
124,435
+7,724
| +7% | +$92K |
2024 Q4
2 quarters
|
|
3280
Pitney Bowes
PBI
$2.29B
| $1.56M | ﹤0.01% |
142,667
-17,734
| -11% | -$167K |
2024 Q4
2 quarters
|
|
3281
AllianzIM U.S. Equity Buffer20 Nov ETF
NVBW
$97.2M
| $1.56M | ﹤0.01% |
48,300
| – | – |
2024 Q4
2 quarters
|
|
3282
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
$453M
| $1.55M | ﹤0.01% |
43,256
+6,720
| +18% | +$227K |
2024 Q4
2 quarters
|
|
3283
Cambria Global Momentum ETF
GMOM
$72.3M
| $1.55M | ﹤0.01% |
52,217
+41,687
| +396% | +$1.2M |
2024 Q4
2 quarters
|
|
3284
Capitol Federal Financial
CFFN
$1.05B
| $1.55M | ﹤0.01% |
253,434
+224,245
| +768% | +$1.27M |
2024 Q4
2 quarters
|
|
3285
Invesco Bloomberg Pricing Power ETF
POWA
$167M
| $1.55M | ﹤0.01% |
17,855
-78
| -0.4% | -$6.46K |
2024 Q4
2 quarters
|
|
3286
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
MFUS
$300M
| $1.54M | ﹤0.01% |
28,797
+74
| +0.3% | +$3.72K |
2024 Q4
2 quarters
|
|
|
THW
3287
abrdn World Healthcare Fund
THW
$503M
| $1.54M | ﹤0.01% |
150,016
-7,429
| -5% | -$78.1K |
2024 Q4
2 quarters
|
|
|
ABFL
3288
Abacus FCF Leaders ETF
ABFL
$531M
| $1.54M | ﹤0.01% |
21,735
+167
| +0.8% | +$11.1K |
2024 Q4
2 quarters
|
|
|
FAX
3289
abrdn Asia-Pacific Income Fund
FAX
$530M
| $1.52M | ﹤0.01% |
95,663
+13,095
| +16% | +$203K |
2024 Q4
2 quarters
|
|
3290
Absolute Select Value ETF
ABEQ
$139M
| $1.52M | ﹤0.01% |
44,385
-11,843
| -21% | -$401K |
2024 Q4
2 quarters
|
|
|
NML
3291
Neuberger Energy Infrastructure and Income Fund Inc
NML
$567M
| $1.52M | ﹤0.01% |
169,049
-4,100
| -2% | -$35K |
2024 Q4
2 quarters
|
|
3292
First Internet Bancorp
INBK
$243M
| $1.52M | ﹤0.01% |
56,471
+7,419
| +15% | +$177K |
2024 Q4
2 quarters
|
|
3293
AllianzIM U.S. Equity Buffer20 Jun ETF
JUNW
$381M
| $1.52M | ﹤0.01% |
47,595
+7,048
| +17% | +$214K |
2024 Q4
2 quarters
|
|
3294
iShares MSCI Canada ETF
EWC
$6.98B
| $1.51M | ﹤0.01% |
32,792
-6,615
| -17% | -$286K |
2024 Q4
2 quarters
|
|
3295
Invesco DB Agriculture Fund
DBA
$1.22B
| $1.51M | ﹤0.01% |
57,685
-22,999
| -29% | -$616K |
2024 Q4
2 quarters
|
|
3296
Angi Inc
ANGI
$232M
| $1.51M | ﹤0.01% |
+98,801
| New | +$1.43M |
2025 Q2
0 quarters
|
|
3297
Innovator US Equity Ultra Buffer ETF April
UAPR
$159M
| $1.51M | ﹤0.01% |
48,109
-1,210
| -2% | -$36.5K |
2024 Q4
2 quarters
|
|
|
SOBO
3298
South Bow Corp
SOBO
$7.01B
| $1.5M | ﹤0.01% |
+57,794
| New | +$1.47M |
2025 Q2
0 quarters
|
|
3299
Lifestance Health
LFST
$4.46B
| $1.5M | ﹤0.01% |
289,540
+414
| +0.1% | +$2.48K |
2025 Q1
1 quarter
|
|
3300
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$663M
| $1.5M | ﹤0.01% |
24,130
-6,249
| -21% | -$363K |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.